← Back to Search

Laser Therapy

Laser Treatment for Port-Wine Stains

N/A
Recruiting
Led By Yakir Levin, MD, PhD
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Have non-facial port wine stain covering at least 30cm2 area on the body
Agree to not undergo any other cosmetic procedure(s) or treatment(s) on the treated areas during the study and has no intention of having such procedures performed during the course of the study
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

This trial looks at how well laser treatment works for port wine birthmarks, comparing two different approaches.

Who is the study for?
This trial is for adults aged 18-75 with non-facial port wine stains covering at least a 30cm2 area. Participants must be able to follow the study's procedures and care instructions, limit sun exposure, and use sunscreen daily. Pregnant or breastfeeding women, those planning pregnancy, or individuals with certain skin conditions or sensitivities are excluded.Check my eligibility
What is being tested?
The study tests the tolerability of an FDA-approved 532 nm laser treatment on port wine stains using two methods: standard single-pulse high fluence and multiple-pulse low fluence. Participants will receive three monthly treatments to compare these approaches.See study design
What are the potential side effects?
Potential side effects may include discomfort during treatment, redness, swelling, bruising in the treated area, changes in skin pigmentation (lighter or darker skin patches), blistering, scarring risk if prone to abnormal healing.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have a port wine stain not on my face that covers at least 30cm2.
Select...
I won't have cosmetic treatments on the study areas during the trial.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Degree of improvement
Secondary outcome measures
Side effects
Subject satisfaction

Trial Design

1Treatment groups
Experimental Treatment
Group I: Port wine stainExperimental Treatment1 Intervention
The port wine stain will be treated with the DermaV laser. Within the single port wine stain, one area will be treated with standard settings (single pulse high fluence). Four other areas will be treated with multi-pulse low fluence settings. A sixth area will be an untreated control.

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
2,935 Previous Clinical Trials
13,198,626 Total Patients Enrolled
2 Trials studying Port-Wine Stain
10 Patients Enrolled for Port-Wine Stain
Yakir Levin, MD, PhDPrincipal InvestigatorMassachusetts General Hospital

Media Library

532 nm laser treatment (Laser Therapy) Clinical Trial Eligibility Overview. Trial Name: NCT05841628 — N/A
Port-Wine Stain Research Study Groups: Port wine stain
Port-Wine Stain Clinical Trial 2023: 532 nm laser treatment Highlights & Side Effects. Trial Name: NCT05841628 — N/A
532 nm laser treatment (Laser Therapy) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05841628 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals over 35 years of age eligible to enroll in this trial?

"This clinical trial is open to individuals aged 18-75. Additionally, there are 1 study and 4 studies respectively for people who are underaged or over the age of retirement."

Answered by AI

For which demographics is enrollment into this trial available?

"This medical trial requires individuals with port-wine stain and aged 18 to 75 for enrollment. As of now, 15 participants have been accepted into the study."

Answered by AI

Is there an opportunity for new participants to join this clinical experiment?

"As per clinicaltrials.gov, this medical study is no longer searching for participants; the trial was first publicized on May 1st 2023 and last amended on April 23rd of the same year. Despite that, there are 5 other studies presently in search of patients at this juncture."

Answered by AI
~3 spots leftby Aug 2024